Stay updated on Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial
Sign up to get notified when there's something new on the Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial page.

Latest updates to the Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA new revision entry v3.5.4 was added to the Record History, and the previous revision v3.5.3 was removed, indicating the page has been updated to the latest version.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedA system/library version label on the page footer was updated from Revision v3.5.2 to Revision v3.5.3, with no corresponding changes to the clinical trial record history or displayed study details.SummaryDifference0.1%

- Check49 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check78 days agoChange DetectedAdded revision: v3.5.0 to the history. Deleted revision: v3.4.3 from the history.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision v3.4.3 was added and revision v3.4.2 was removed, reflecting an administrative update to the page history rather than any study content changes.SummaryDifference0.1%

- Check114 days agoChange DetectedThe record history shows a minor revision update from v3.4.1 to v3.4.2; there are no changes to study data, design, or substantive content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial page.